Upon approval of Pluristem’s investigational new drug and investigational medicinal product dossier submissions in the US and Europe, Pluristem plans to initiate Phase I clinical trials by administering
Financial highlights Research and development expenses Research and development expenses increased to AUD11,585,258 in 2008 from AUD7,157,216 in 2007. General and administrative expenses General and administrative expenses increased
In this new role, Vertatschitsch will oversee all engineering, clinical, information technology and manufacturing operations Jed Palmacci has widespread experience building and managing global sales organizations within successful
Sheila DeWitt, Epix’s former head of business development and current vice president of discovery and manufacturing, will lead the company’s business development efforts going forward. Dr DeWitt joined
Constructed using the Biomerix Biomaterial, Revive acts as a tissue scaffold facilitating rapid tissue ingrowth and can be utilized in a variety of soft tissue repair procedures, including
Under the terms of the contract, Skytron’s North American network of independent distributors will exclusively offer the patented Awarepoint real-time location system (RTLS) technology, marketed under the name,
As the CFO, Mr Komatz will plan and manage the company’s financial and accounting activities, and will communicate information about them to the board of directors and others.
With the consummation of the merger, Targanta has become a wholly owned subsidiary of The Medicines Company. Clive Meanwell, chairman and CEO of The Medicines Company, said: “This
Access gains the rights to MacroChem’s product portfolio which includes two clinical stage oncology products, 4-thio Ara-C (thiarabine), which is a next generation nucleoside analogue licensed from Southern
Cyclogenix has granted Wyeth exclusive rights to Cyclogenix’s novel drug discovery technology platform for use in generating therapeutic peptides, and Wyeth will fund research activities focused on using
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.